US$ 28.44
glp-1 fatty liver disease GLP1 Therapy Gains Traction Treating Glucagon-like peptide 1 and fibroblast
Description
New England Journal of Medicine , 337 (9), 581-588

From initial consultation to ongoing support, Claya ensures that patients can maintain their progress without the disruptions caused by medication shortages

Effect of tirzepatide on blood pressure and lipids: a meta-analysis of randomized controlled trials

Grespan E, Giorgino T, Natali A, Ferrannini E, Mari A

doi: 10.2337/dci20-0023
